Cited by

• Physiologically based modeling of the pharmacokinetics of acetaminophen and its major metabolites in humans using a Bayesian population approach.

  Zurlinden TJ, Reisfeld B. Zurlinden TJ, et al. Eur J Drug Metab Pharmacokinet. 2016 Jun;41(3):267-80. doi: 10.1007/s13318-015-0253-x. Epub 2015 Jan 31. Eur J Drug Metab Pharmacokinet. 2016. PMID: 25636597
• In silico screening for potential inhibitors from the phytocompounds of Carica papaya against Zika virus NS5 protein.

  Kumaree KK, Anthikapalli NVA, Prasansuklab A. Kumaree KK, et al. F1000Res. 2024 Jun 25;12:655. doi: 10.12688/f1000research.134956.2. eCollection 2023. F1000Res. 2024. PMID: 39132582 Free PMC article.
• Determination of a human hepatic microsomal scaling factor for predicting in vivo drug clearance.

  Hakooz N, Ito K, Rawden H, Gill H, Lemmers L, Boobis AR, Edwards RJ, Carlile DJ, Lake BG, Houston JB. Hakooz N, et al. Pharm Res. 2006 Mar;23(3):533-9. doi: 10.1007/s11095-006-9531-2. Epub 2006 Feb 28. Pharm Res. 2006. PMID: 16505976
• Exploring stereoselective excretion and metabolism studies of novel 2-(2-hydroxypropanamido)-5-trifluoromethyl benzoic acid enantiomers.

  Rong R, Zhang QL, Zhang RZ, Dan YH, Wang X, Zhao YL, Yu ZG. Rong R, et al. RSC Adv. 2020 Jul 21;10(46):27267-27279. doi: 10.1039/d0ra03500a. eCollection 2020 Jul 21. RSC Adv. 2020. PMID: 35516918 Free PMC article.
• Screening of drug candidates against Endothelin-1 to treat hypertension using computational based approaches: Molecular docking and dynamics simulation.

  Fatima I, Ihsan H, Masoud MS, Kalsoom S, Aslam S, Rehman A, Ashfaq UA, Qasim M. Fatima I, et al. PLoS One. 2022 Aug 18;17(8):e0269739. doi: 10.1371/journal.pone.0269739. eCollection 2022. PLoS One. 2022. Retraction in: PLoS One. 2023 Apr 26;18(4):e0284670. doi: 10.1371/journal.pone.0284670. PMID: 35981003 Free PMC article. Retracted.